-

Vicarious Surgical Receives Three Built In Boston’s 2022 Best Places to Work Awards

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical is proud to announce it has been honored with three awards from Built In’s 2022 Best Places To Work Awards. Specifically, Vicarious Surgical earned a place in the following three categories in Boston: Best Places to Work, Best Midsize Companies to Work for, and Best Paying Companies. The annual awards program includes companies of all sizes, from startups to large enterprises, and honors companies in the eight largest tech markets across the U.S. as well as remote-first companies.

“Our employees are our greatest assets and providing them with the culture and benefits worthy of the tremendous work they do every day is of the outmost importance,” said Adam Sachs, CEO of Vicarious Surgical. “We are honored to be recognized by Built In Boston, as a Best Place to Work in three categories and are sincerely dedicated to our employees’ success as our company continues to grow.”

Built In determines the winners of Best Places to Work based on an algorithm, using company data about compensation, benefits and company-wide programming. To reflect the benefits candidates are searching for more frequently on Built In, the program weighs criteria like remote and flexible work opportunities, programs for DEI and other people-first cultural offerings.

“It is my honor to extend congratulations to the 2022 Best Places to Work winners,” said Sheridan Orr, chief marketing officer, Built In. “This year saw a record number of entrants — and the past two years fundamentally changed what tech professionals want from work. These honorees have risen to the challenge, evolving to deliver employee experiences that provide the meaning and purpose today’s tech professionals seek.”

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company’s novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. The Company’s technology was granted Breakthrough Device Designation by the FDA, and Vicarious Surgical believes the Vicarious System is the first surgical robot to receive this designation from the FDA. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Mass. Learn more about the company and career opportunities at www.vicarioussurgical.com.

About Built In

Built In is creating the largest platform for technology professionals globally. Monthly, more than three million of the industry’s most in-demand professionals visit the site from across the world. They rely on our platform to stay ahead of tech trends and news, develop their careers and find opportunities at companies whose values they share. Built In also serves 1,800 innovative companies of all sizes, ranging from startups to the Fortune 100. By putting their stories in front of our uniquely engaged audience, we help them hire otherwise hard-to-reach tech professionals, locally, nationally or remotely. Visit www.builtin.com

Contacts

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
ir@vicarioussurgical.com

Press and Media Inquiries:
Jill Gross
Matter Communications
media@vicarioussurgical.com

Vicarious Surgical

NYSE:RBOT

Release Versions

Contacts

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
ir@vicarioussurgical.com

Press and Media Inquiries:
Jill Gross
Matter Communications
media@vicarioussurgical.com

More News From Vicarious Surgical

Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced an update to full-year 2025 financial guidance. Vicarious Surgical now expects full-year 2025 cash burn of approximately $45 million, representing a $5 million improvement from its previous guidance of $50 million. The improved guidance reflects disciplined cost management initiativ...

Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that the Company will participate in the upcoming Piper Sandler 37th Annual Healthcare Conference. Vicarious Surgical’s management is scheduled to participate in a fireside discussion on Wednesday, December 3, 2025, at 4:30 p.m. Eastern Standard Time. Interes...

Vicarious Surgical Reports Third Quarter 2025 Financial Results

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the third quarter ended September 30, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, November 12, 2025. “Since stepping into this role three months ago, my focus has been on sharpening our execution and...
Back to Newsroom